FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maurizio Zangari

Research Profile

Disorders

Multiple Myeloma

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Maurizio Zangari; Jerry L Spivak; Brady L Stein; Sabina I Swierczek; Giulia Tolomelli; Tamara Berno; Louis Fink; Victor R Gordeuk; Kimberly Hickman; Todd W Kelley; Jasmine C H Lee; Alison R Moliterno; Josef T Prchal
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?
Wen Zhou; David Bearss; Tiehua Chen; Rodney Miles; Mohamed E Salama; Shashirekha Shetty; Lei Shi; Guido Tricot; He Wang; Jiliang Xia; Wei Xiong; Hongwei Xu; Ye Yang; Maurizio Zangari; Zhaoyang Zeng; Fenghuang Zhan
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.
Maurizio Zangari; Fenghuang Zhan; Evangelos Terpos; Guido Tricot
Impact of bortezomib on bone health in myeloma: a review of current evidence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maurizio Zangari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maurizio Zangari; Jerry L Spivak; Brady L Stein; Sabina I Swierczek; Giulia Tolomelli; Tamara Berno; Louis Fink; Victor R Gordeuk; Kimberly Hickman; Todd W Kelley; Jasmine C H Lee; Alison R Moliterno; Josef T Prchal
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2013;24(3):311-6.
2013: Wen Zhou; David Bearss; Tiehua Chen; Rodney Miles; Mohamed E Salama; Shashirekha Shetty; Lei Shi; Guido Tricot; He Wang; Jiliang Xia; Wei Xiong; Hongwei Xu; Ye Yang; Maurizio Zangari; Zhaoyang Zeng; Fenghuang Zhan
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.
Cancer cell 2013;23(1):48-62.
2012: Maurizio Zangari; Fenghuang Zhan; Evangelos Terpos; Guido Tricot
Impact of bortezomib on bone health in myeloma: a review of current evidence.
Cancer treatment reviews 2012;38(8):968-80.
2012: Maurizio Zangari; Fenghuang Zhan; Tamara Berno; Guido Tricot; Louis Fink
Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs.
Seminars in thrombosis and hemostasis 2012;38(8):768-79.
2012: Jong Hun Kim; Mary Lampas; Stephanie Sanders; Guido Tricot; Maurizio Zangari; Claudia Goulston; Kimberly E Hanson
Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1753-8.
2012: Tiehua Chen; Tamara Berno; Maurizio Zangari
Low-risk identification in multiple myeloma using a new 14-gene model.
European journal of haematology 2012;89(1):28-36.
2011: Maurizio Zangari; Fenghuang Zhan; Suzanne Trudel; Ravi Vij; Luhua Wang; Monette Aujay; Nizar Bahlis; Andrew Belch; Tamara Berno; Kristina L Hetherington; Sundar Jagannath; Andrzej Jakubowiak; A Keith Stewart; Vishal Kukreti; Sagar Lonial; Robert Z Orlowski; David Siegel; Seema Singhal; George Somlo; Guido Tricot
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
European journal of haematology 2011;86(6):484-7.
2011: Maurizio Zangari; Louis Fink; Fenghuang Zhan; Guido Tricot
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.
Clinical lymphoma, myeloma & leukemia 2011;11(2):228-36.
2011: Maurizio Zangari; Shmuel Yaccoby; Lisa M Pappas; Federica Cavallo; Naveen Sanath Kumar; Subramanian Ranganathan; Larry J Suva; J Michael Gruenwald; Steven Kern; Fenghuang Zhan; Dixie Esseltine; Guido Tricot
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients.
Haematologica 2011;96(2):333-6.
2011: Richard Dela Cruz; Guido Tricot; Maurizio Zangari; Fenghuang Zhan
Progress in myeloma stem cells.
American journal of blood research 2011;1(2):135-45.
2010: Maurizio Zangari; Fenghuang Zhan; Guido Tricot
Bone and paraproteinemias.
Current opinion in supportive and palliative care 2010;4(3):195-9.
2010: Lei Shi; Siqing Wang; Maurizio Zangari; Hongwei Xu; Thai M Cao; Chunjiao Xu; Yong Wu; Fang Xiao; Yinghong Liu; Ye Yang; Mohamed Salama; Guiyuan Li; Guido Tricot; Fenghuang Zhan
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.
Oncotarget 2010;1(1):22-33.
2010: Maurizio Zangari; Guido Tricot; Latha Polavaram; Fenghuang Zhan; Ashlie Finlayson; Robert Knight; Tommy Fu; Donna Weber; Meletios A Dimopoulos; Ruben Niesvizky; Louis Fink
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):132-5.
2009: Maurizio Zangari; Louis M Fink; Francesca Elice; Fenghuang Zhan; Dorothy M Adcock; Guido J Tricot
Thrombotic events in patients with cancer receiving antiangiogenesis agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(29):4865-73.
2009: Siqing Wang; Guido Tricot; Lei Shi; Wei Xiong; Zhaoyang Zeng; Hongwei Xu; Maurizio Zangari; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.
Blood 2009;114(3):600-7.
2009: Guido Tricot; Maurizio Zangari; Roberto Sorasio; Benedetto Bruno
Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.
Cancer treatment and research 2009;144():317-55.
2009: Maurizio Zangari; F Elice; Guido Tricot; L Fink
Bleeding disorders associated with cancer dysproteinemias.
Cancer treatment and research 2009;148():295-304.
2009: Angela Pennisi; Xin Li; Wen Ling; Sharmin Khan; Maurizio Zangari; Shmuel Yaccoby
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.
American journal of hematology 2009;84(1):6-14.
2008: Giampaolo Talamo; David Claxton; Guido Tricot; Louis Fink; Maurizio Zangari
Response to bortezomib in refractory type I cryoglobulinemia.
American journal of hematology 2008;83(11):883-4.
2008: Guido Tricot; Bart Barlogie; Maurizio Zangari; Frits van Rhee; Antje Hoering; Jackie Szymonifka; Michele Cottler-Fox
Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.
Haematologica 2008;93(11):1739-42.
2008: Bart Barlogie; Mauricio Pineda-Roman; Frits van Rhee; Jeffrey Haessler; Elias Anaissie; Klaus Hollmig; Yazan Alsayed; Sarah Waheed; Nathan Petty; Joshua Epstein; John D Shaughnessy; Guido Tricot; Maurizio Zangari; Jerome B Zeldis; Sol Barer; John Crowley
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
Blood 2008;112(8):3115-21.
2008: Dorothy M Adcock; Louis M Fink; Richard A Marlar; Federica Cavallo; Maurizio Zangari
The hemostatic system and malignancy.
Clinical lymphoma & myeloma 2008;8(4):230-6.
2008: Mauricio Pineda-Roman; Maurizio Zangari; Frits van Rhee; Elias Anaissie; J Szymonifka; Antje Hoering; N Petty; John Crowley; John Shaughnessy; Joshua Epstein; Bart Barlogie
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.
Leukemia 2008;22(7):1419-27.
2008: Maurizio Zangari; Jose Guerrero; Federica Cavallo; H Keshava Prasad; Dixie Esseltine; Louis Fink
Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.
Haematologica 2008;93(6):953-4.
2008: Maurizio Zangari; Frits van Rhee; Elias Anaissie; Mauricio Pineda-Roman; Jeffrey Haessler; John Crowley; Bart Barlogie
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.
British journal of haematology 2008;141(4):433-44.
2008: Mauricio Pineda-Roman; Bart Barlogie; Elias Anaissie; Maurizio Zangari; Vanessa Bolejack; Frits van Rhee; Guido Tricot; John Crowley
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.
Cancer 2008;112(8):1754-64.
2008: Mauricio Pineda-Roman; Maurizio Zangari; Jeffrey Haessler; Elias Anaissie; Guido Tricot; Frits van Rhee; John Crowley; John D Shaughnessy; Bart Barlogie
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.
British journal of haematology 2008;140(6):625-34.
2008: Bart Barlogie; Guido Tricot; Jeff Haessler; Frits van Rhee; Michele Cottler-Fox; Elias Anaissie; James Waldron; Mauricio Pineda-Roman; Raymond Thertulien; Maurizio Zangari; Klaus Hollmig; Abid Mohiuddin; Yazan Alsayed; Antje Hoering; John Crowley; Jeffrey Sawyer
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
Blood 2008;111(1):94-100.
2007: Bart Barlogie; Elias Anaissie; Frits van Rhee; Mauricio Pineda-Roman; Maurizio Zangari; John Shaughnessy; Joshua Epstein; John Crowley
The Arkansas approach to therapy of patients with multiple myeloma.
Best practice & research. Clinical haematology 2007;20(4):761-81.
2007: Jeffrey Haessler; John D Shaughnessy; Fenghuang Zhan; John Crowley; Joshua Epstein; Frits van Rhee; Elias Anaissie; Mauricio Pineda-Roman; Maurizio Zangari; Klaus Hollmig; Abid Mohiuddin; Yazan Alsayed; Antje Hoering; Guido Tricot; Bart Barlogie
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7073-9.
2007: Edward A Stadtmauer; Sagar Lonial; David H Vesole; Rafat Abonour; Melissa Alsina; Ashraf Badros; Raymond Comenzo; Brian G M Durie; Sergio Giralt; Mohamad Hussein; Andrzej J Jakubowiak; Jayesh Mehta; Ruben Niesvizky; Robert Z Orlowski; David Siegel; Seema Singhal; Robert A Vescio; Michael Wang; Maurizio Zangari; Nikhil C Munshi
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clinical advances in hematology & oncology : H&O 2007;5(10 Suppl 15):7-19, quiz 21-2.
2007: Maurizio Zangari; Bart Barlogie; Federica Cavallo; Vanessa Bolejack; Louis Fink; Guido Tricot
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(7):595-8.
2007: Maurizio Zangari; Dixie Esseltine; Federica Cavallo; Rachel Neuwirth; Francesca Elice; Michael J Burns; Shmuel Yaccoby; Paul G Richardson; Pieter Sonneveld; Guido Tricot
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
American journal of hematology 2007;82(9):831-3.
2007: Frits van Rhee; Vanessa Bolejack; Klaus Hollmig; Mauricio Pineda-Roman; Elias Anaissie; Joshua Epstein; John D Shaughnessy; Maurizio Zangari; Guido Tricot; Abid Mohiuddin; Yazan Alsayed; Gail Woods; John Crowley; Bart Barlogie
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
Blood 2007;110(3):827-32.
2007: Bart Barlogie; Elias Anaissie; Frits van Rhee; Jeffrey Haessler; Klaus Hollmig; Mauricio Pineda-Roman; Michele Cottler-Fox; Abid Mohiuddin; Yazan Alsayed; Guido Tricot; Vanessa Bolejack; Maurizio Zangari; Joshua Epstein; Nathan Petty; Douglas Steward; Bonnie Jenkins; Jennifer Gurley; Ellen Sullivan; John Crowley; John D Shaughnessy
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
British journal of haematology 2007;138(2):176-85.
2007: Maurizio Zangari; Francesca Elice; Louis Fink; Guido Tricot
Hemostatic dysfunction in paraproteinemias and amyloidosis.
Seminars in thrombosis and hemostasis 2007;33(4):339-49.
2007: John D Shaughnessy; Jeffrey Haessler; Frits van Rhee; Elias Anaissie; Mauricio Pineda-Roman; Michele Cottler-Fox; Klaus Hollmig; Maurizio Zangari; Abid Mohiuddin; Yazan Alsayed; Monica Grazziutti; Joshua Epstein; John Crowley; Bart Barlogie
Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
British journal of haematology 2007;137(6):530-6.
2007: Giampaolo Talamo; Federica Cavallo; Maurizio Zangari; Bart Barlogie; Choon-Kee Lee; Mauricio Pineda-Roman; Elias Kiwan; Somashekar Krishna; Guido Tricot
Hyperammonemia and encephalopathy in patients with multiple myeloma.
American journal of hematology 2007;82(5):414-5.
2007: Ronald Walker; Bart Barlogie; Jeffrey Haessler; Guido Tricot; Elias Anaissie; John D Shaughnessy; Joshua Epstein; Rudy Van Hemert; Eren Erdem; Antje Hoering; John Crowley; Ernest J Ferris; Klaus Hollmig; Frits van Rhee; Maurizio Zangari; Mauricio Pineda-Roman; Abid Mohiuddin; Shmuel Yaccoby; Jeffrey Sawyer; Edgardo Angtuaco
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1121-8.
2007: John D Shaughnessy; Fenghuang Zhan; Bart E Burington; Yongsheng Huang; Simona Colla; Ichiro Hanamura; James P Stewart; Bob Kordsmeier; Christopher Randolph; David R Williams; Yan Xiao; Hongwei Xu; Joshua Epstein; Elias Anaissie; Somashekar G Krishna; Michele Cottler-Fox; Klaus Hollmig; Abid Mohiuddin; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Jeffrey Sawyer; Yazan Alsayed; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
Blood 2007;109(6):2276-84.
2007: Maurizio Zangari; Francesca Elice; Louis Fink; Guido Tricot
Thrombosis in multiple myeloma.
Expert review of anticancer therapy 2007;7(3):307-15.
2007: Fenghuang Zhan; Bart Barlogie; Varant Arzoumanian; Yongsheng Huang; David R Williams; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Maurizio Zangari; Madhav V Dhodapkar; John D Shaughnessy
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
Blood 2007;109(4):1692-700.
2007: Mauricio Pineda-Roman; Vanessa Bolejack; Varant Arzoumanian; Elias Anaissie; Frits van Rhee; Maurizio Zangari; Ron Walker; Klaus Hollmig; John D Shaughnessy; Joshua Epstein; Somashekar Krishna; John Crowley; Bart Barlogie
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
British journal of haematology 2007;136(3):393-9.
2006: Maurizio Zangari; Federica Cavallo; Guido Tricot
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myeloma.
Current pharmaceutical biotechnology 2006;7(6):449-53.
2006: Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart E Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
The molecular classification of multiple myeloma.
Blood 2006;108(6):2020-8.
2006: Maurizio Zangari
Anticoagulation regimens for thalidomide and lenalidomide.
Clinical advances in hematology & oncology : H&O 2006;4(9):658-9.
2006: Maurizio Zangari; Shmuel Yaccoby; Federica Cavallo; Dixie Esseltine; Guido Tricot
Response to bortezomib and activation of osteoblasts in multiple myeloma.
Clinical lymphoma & myeloma 2006;7(2):109-14.
2006: Francesca Elice; Louis Fink; Guido Tricot; Bart Barlogie; Maurizio Zangari
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
British journal of haematology 2006;134(4):399-405.
2006: Giampaolo Talamo; Federica Cavallo; Maurizio Zangari; Bart Barlogie; Choon-Kee Lee; Mauricio Pineda-Roman; Elias Kiwan; Somashekar Krishna; Guido Tricot
Clinical and biological features of multiple myeloma involving the gastrointestinal system.
Haematologica 2006;91(7):964-7.
2006: Bart Barlogie; Maurizio Zangari; Vanessa Bolejack; Klaus Hollmig; Elias Anaissie; Frits van Rhee; Mauricio Pineda-Roman; Abid Mohiuddin; John Crowley; Guido Tricot
Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.
Clinical lymphoma & myeloma 2006;6(6):469-74.
2006: Bart Barlogie; Guido Tricot; Erik Rasmussen; Elias Anaissie; Frits van Rhee; Maurizio Zangari; AB Fassas; Klaus Hollmig; Mauricio Pineda-Roman; John Shaughnessy; Joshua Epstein; John Crowley
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies.
Blood 2006;107(7):2633-8.
2006: Bart Barlogie; Guido Tricot; Elias Anaissie; John Shaughnessy; Erik Rasmussen; Frits van Rhee; AB Fassas; Maurizio Zangari; Klaus Hollmig; Mauricio Pineda-Roman; Choon Lee; Giampaolo Talamo; Raymond Thertulien; Elias Kiwan; Somashekar Krishna; Michele Fox; John Crowley
Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
The New England journal of medicine 2006;354(10):1021-30.
2006: Choon-Kee Lee; Maurizio Zangari; AB Fassas; Raymond Thertulien; Giampaolo Talamo; Ashraf Badros; Michele Cottler-Fox; Frits van Rhee; Bart Barlogie; Guido Tricot
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation.
Bone marrow transplantation 2006;37(5):511-5.
2006: Shmuel Yaccoby; Michele Wezeman; Maurizio Zangari; Ronald Walker; Michele Cottler-Fox; Danna Gaddy; Wen Ling; Rinku Saha; Bart Barlogie; Guido Tricot; Joshua Epstein
Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
Haematologica 2006;91(2):192-9.
2005: Maurizio Zangari; Francesca Elice; Guido Tricot
Immunomodulatory drugs in multiple myeloma.
Expert opinion on investigational drugs 2005;14(11):1411-8.
2005: Maurizio Zangari; Dixie Esseltine; Choon-Kee Lee; Bart Barlogie; Francesca Elice; Michael J Burns; Seung-Hee Kang; Shmuel Yaccoby; Kevin Najarian; Paul G Richardson; Pieter Sonneveld; Guido Tricot
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
British journal of haematology 2005;131(1):71-3.
2005: Giampaolo Talamo; Edgardo Angtuaco; Ronald C Walker; Li Dong; Marisa H Miceli; Maurizio Zangari; Guido Tricot; Bart Barlogie; Elias Anaissie
Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5217-23.
2004: Maurizio Zangari; Bart Barlogie; Elias Anaissie; Fariba Saghafifar; Paul Eddlemon; Joth Jacobson; Choon-Kee Lee; Raymond Thertulien; Giampaolo Talamo; Teri Thomas; Frits van Rhee; AB Fassas; Louis Fink; Guido Tricot
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
British journal of haematology 2004;126(5):715-21.
2004: Choon-Kee Lee; Maurizio Zangari; Bart Barlogie; AB Fassas; Frits van Rhee; Raymond Thertulien; Giampaolo Talamo; Firas Muwalla; Elias Anaissie; Klaus Hollmig; Guido Tricot
Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
Bone marrow transplantation 2004;33(8):823-8.
2004: Maurizio Zangari; Elias Anaissie; Alison T Stopeck; Alyssa Morimoto; Nguyen Tan; Jeffrey E Lancet; Maureen Cooper; Alison L Hannah; Guillermo Garcia-Manero; Stefan Faderl; Andrew Lamb; Julie M Cherrington; Maher Albitar; Francis Giles
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):88-95.
2004: Bart Barlogie; John Shaughnessy; Guido Tricot; Joth Jacobson; Maurizio Zangari; Elias Anaissie; Ron Walker; John Crowley
Treatment of multiple myeloma.
Blood 2004;103(1):20-32.
2003: Thomas Kelly; Hua-Quan Miao; Yang Yang; Elizabeth Navarro; Paul Kussie; Yan Huang; Veronica MacLeod; Jonathan Casciano; Lija Joseph; Fenghuang Zhan; Maurizio Zangari; Bart Barlogie; John Shaughnessy; Ralph D Sanderson
High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Cancer research 2003;63(24):8749-56.
2003: AB Fassas; Bart Barlogie; Susan Ward; Sundar Jagannath; David H Vesole; Sandy Mattox; David Siegel; Firas Muwalla; Maurizio Zangari; Elias Anaissie; Frits Van Rhee; Raymond Thertulien; Choon-Kee Lee; Raman Desikan; Varant Arzumanian; Jason McCoy; Guido Tricot
Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.
British journal of haematology 2003;123(3):484-9.
2003: Joth Jacobson; Bart Barlogie; John Shaughnessy; Johannes Drach; Guido Tricot; AB Fassas; Maurizio Zangari; Dori Giroux; John Crowley; Aubrey Hough; Jeffrey Sawyer
MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants.
British journal of haematology 2003;122(3):430-40.
2003: Choon-Kee Lee; Bart Barlogie; Nikhil Munshi; Maurizio Zangari; AB Fassas; Joth Jacobson; Frits van Rhee; Michele Cottler-Fox; Firas Muwalla; Guido Tricot
DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2732-9.
2003: Maurizio Zangari; Fariba Saghafifar; Paulette Mehta; Bart Barlogie; Louis Fink; Guido Tricot
The blood coagulation mechanism in multiple myeloma.
Seminars in thrombosis and hemostasis 2003;29(3):275-82.
2003: Maurizio Zangari; Bart Barlogie; Raymond Thertulien; Joth Jacobson; Paul Eddleman; Louis Fink; AB Fassas; Frits van Rhee; Giampaolo Talamo; Choon-Kee Lee; Guido Tricot
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.
Clinical lymphoma 2003;4(1):32-5.
2003: John Shaughnessy; Joth Jacobson; Jeffrey Sawyer; Jason McCoy; AB Fassas; Fenghuang Zhan; Klaus Bumm; Joshua Epstein; Elias Anaissie; Sundar Jagannath; David H Vesole; David Siegel; Raman Desikan; Nikhil Munshi; Ashraf Badros; Erming Tian; Maurizio Zangari; Guido Tricot; John Crowley; Bart Barlogie
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression.
Blood 2003;101(10):3849-56.
2003: Francis Giles; Maureen A Cooper; Lewis Silverman; Judith E Karp; Jeffrey E Lancet; Maurizio Zangari; Paul J Shami; Khuda Dad Khan; Alison L Hannah; Julie M Cherrington; Deborah A Thomas; Guillermo Garcia-Manero; Maher Albitar; Hagop M Kantarjian; Alison T Stopeck
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
Cancer 2003;97(8):1920-8.
2003: Raman Desikan; Bart Barlogie; Rajesh Sethi; Amir Toor; Dan Spoon; Edgardo Angtuaco; Rudy Vanhemert; Anantha VijayaGopal; shashank singhal; Jayesh Mehta; Sundar Jagannath; Nikhil Munshi; Maurizio Zangari; AB Fassas; Guido Tricot; Elias Anaissie
Infection--an underappreciated cause of bone pain in multiple myeloma.
British journal of haematology 2003;120(6):1047-50.
2003: Christopher L Morris; Eric Siegel; Bart Barlogie; Michele Cottler-Fox; Pei Lin; AB Fassas; Maurizio Zangari; Elias Anaissie; Guido Tricot
Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen.
British journal of haematology 2003;120(3):413-23.
2003: Choon-Kee Lee; Ashraf Badros; Bart Barlogie; Christopher Morris; Maurizio Zangari; AB Fassas; Frits van Rhee; Michele Cottler-Fox; Joth Jacobson; Raymond Thertulien; Firas Muwalla; Syed Mazher; Elias Anaissie; Guido Tricot
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.
Experimental hematology 2003;31(1):73-80.
2003: John Shaughnessy; Erming Tian; Jeffrey Sawyer; Jason McCoy; Guido Tricot; Joth Jacobson; Elias Anaissie; Maurizio Zangari; AB Fassas; Firas Muwalla; Christopher Morris; Bart Barlogie
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.
British journal of haematology 2003;120(1):44-52.
2002: Bart Barlogie; John Shaughnessy; Maurizio Zangari; Guido Tricot
High-dose therapy and immunomodulatory drugs in multiple myeloma.
Seminars in oncology 2002;29(6 Suppl 17):26-33.
2002: Choon-Kee Lee; Bart Barlogie; Maurizio Zangari; AB Fassas; Elias Anaissie; Christopher Morris; Frits van Rhee; Michele Cottler-Fox; Raymond Thertulien; Firas Muwalla; S Mazher; Ashraf Badros; Guido Tricot
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
Bone marrow transplantation 2002;30(12):873-8.
2002: AB Fassas; Horace Spencer; Raman Desikan; Maurizio Zangari; Elias Anaissie; Bart Barlogie; Guido Tricot
Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients.
British journal of haematology 2002;119(1):164-8.
2002: Nikhil C Munshi; Guido Tricot; Raman Desikan; Ashraf Badros; Maurizio Zangari; Amir Toor; C Morris; Elias Anaissie; Bart Barlogie
Clinical activity of arsenic trioxide for the treatment of multiple myeloma.
Leukemia 2002;16(9):1835-7.
2002: AB Fassas; Horace Spencer; Jeffrey Sawyer; Maurizio Zangari; Choon-Kee Lee; Elias Anaissie; Firas Muwalla; Christopher Morris; Bart Barlogie; Guido Tricot
Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma.
British journal of haematology 2002;118(4):1041-7.
2002: Maurizio Zangari; Eric Siegel; Bart Barlogie; Elias Anaissie; Fariba Saghafifar; AB Fassas; Christopher Morris; Louis Fink; Guido Tricot
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy.
Blood 2002;100(4):1168-71.
2002: Varsha Kaushal; Manish Kohli; Maurizio Zangari; Louis Fink; Paulette Mehta
Endothelial dysfunction in antiangiogenesis-associated thrombosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):3042; author reply 3042-3.
2002: Ashraf Badros; Christopher Morris; Maurizio Zangari; Bart Barlogie; Guido Tricot
Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Leukemia & lymphoma 2002;43(6):1267-71.
2002: Maurizio Zangari; Fariba Saghafifar; Elias Anaissie; Ashraf Badros; Raman Desikan; AB Fassas; Paulette Mehta; Christopher Morris; Amir Toor; D Whitfield; Eric Siegel; Bart Barlogie; Louis Fink; Guido Tricot
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):187-92.
2002: AB Fassas; Firas Muwalla; Tanya Berryman; Riad Benramdane; Lija Joseph; Elias Anaissie; Rajesh Sethi; Raman Desikan; David Siegel; Ashraf Badros; Amir Toor; Maurizio Zangari; Christopher Morris; Edgardo Angtuaco; Sajini Mathew; Carla Wilson; Aubrey Hough; Sami I Harik; Bart Barlogie; Guido Tricot
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
British journal of haematology 2002;117(1):103-8.
2002: Ashraf Badros; Eric Siegel; Donald L Bodenner; Maurizio Zangari; Jerome B Zeldis; Bart Barlogie; Guido Tricot
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
The American journal of medicine 2002;112(5):412-3.
2002: Ashraf Badros; Bart Barlogie; Eric Siegel; Michele Cottler-Fox; Maurizio Zangari; AB Fassas; Christopher Morris; Elias Anaissie; Frits van Rhee; Guido Tricot
Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1295-303.
2002: Fenghuang Zhan; Johanna Hardin; Bob Kordsmeier; Klaus Bumm; Mingzhong Zheng; Erming Tian; Ralph D Sanderson; Yang Yang; Carla Wilson; Maurizio Zangari; Elias Anaissie; Christopher Morris; Firas Muwalla; Frits van Rhee; AB Fassas; John Crowley; Guido Tricot; Bart Barlogie; John Shaughnessy
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.
Blood 2002;99(5):1745-57.
2002: Guido Tricot; Horace Spencer; Jeffrey Sawyer; Dan Spoon; Raman Desikan; AB Fassas; Ashraf Badros; Maurizio Zangari; Nikhil Munshi; Elias Anaissie; Amir Toor; Bart Barlogie
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants.
British journal of haematology 2002;116(1):211-7.
2001: Ashraf Badros; Bart Barlogie; Eric Siegel; J Roberts; C Langmaid; Maurizio Zangari; Raman Desikan; Mary J Shaver; AB Fassas; S McConnell; Firas Muwalla; Yousri M Barri; Elias Anaissie; Nikhil Munshi; Guido Tricot
Results of autologous stem cell transplant in multiple myeloma patients with renal failure.
British journal of haematology 2001;114(4):822-9.
2001: Ashraf Badros; Bart Barlogie; Eric Siegel; Christopher Morris; Raman Desikan; Maurizio Zangari; AB Fassas; Elias Anaissie; Nikhil Munshi; Guido Tricot
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years.
British journal of haematology 2001;114(3):600-7.
2001: Maurizio Zangari; Elias Anaissie; Bart Barlogie; Ashraf Badros; Raman Desikan; A V Gopal; Christopher Morris; Amir Toor; Eric Siegel; Louis Fink; Guido Tricot
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.
Blood 2001;98(5):1614-5.
2001: Bart Barlogie; Raman Desikan; Paul Eddlemon; Horace Spencer; Jerome B Zeldis; Nikhil Munshi; Ashraf Badros; Maurizio Zangari; Elias Anaissie; Joshua Epstein; John Shaughnessy; D Ayers; Dan Spoon; Guido Tricot
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.
Blood 2001;98(2):492-4.
2001: Bart Barlogie; Maurizio Zangari; Horace Spencer; AB Fassas; Elias Anaissie; Ashraf Badros; Jeana Cromer; Guido Tricot
Thalidomide in the management of multiple myeloma.
Seminars in hematology 2001;38(3):250-9.
2001: Ashraf Badros; Bart Barlogie; Christopher Morris; Raman Desikan; S R Martin; Nikhil Munshi; Maurizio Zangari; Jayesh Mehta; Amir Toor; Michele Cottler-Fox; AB Fassas; Elias Anaissie; Steven A Schichman; Guido Tricot; E Aniassie
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions.
Blood 2001;97(9):2574-9.
2001: KR Desikan; Guido Tricot; Nikhil C Munshi; Elias Anaissie; Dan Spoon; AB Fassas; Amir Toor; Maurizio Zangari; Ashraf Badros; Christopher Morris; David H Vesole; David Siegel; Sundar Jagannath; Bart Barlogie
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.
British journal of haematology 2001;112(1):242-7.
2000: Raman Desikan; Bart Barlogie; Jeffrey Sawyer; D Ayers; Guido Tricot; Ashraf Badros; Maurizio Zangari; Nikhil C Munshi; Elias Anaissie; Dan Spoon; David Siegel; Sundar Jagannath; David H Vesole; Joshua Epstein; John Shaughnessy; AB Fassas; S Lim; P Roberson; John Crowley
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.
Blood 2000;95(12):4008-10.